TY - JOUR
T1 - Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease
AU - Kamata, Hirofumi
AU - Asakura, Takanori
AU - Suzuki, Shoji
AU - Namkoong, Ho
AU - Yagi, Kazuma
AU - Funatsu, Yohei
AU - Okamori, Satoshi
AU - Uno, Shunsuke
AU - Uwamino, Yoshifumi
AU - Fujiwara, Hiroshi
AU - Nishimura, Tomoyasu
AU - Ishii, Makoto
AU - Betsuyaku, Tomoko
AU - Hasegawa, Naoki
N1 - Publisher Copyright:
© 2017 The Author(s).
PY - 2017/12/13
Y1 - 2017/12/13
N2 - Background: In bronchiectasis patients, chronic Pseudomonas aeruginosa (PA) infection has been associated with worse health-related quality of life (HRQL), but little is known about Mycobacterium avium complex lung disease (MACLD) patients in this context. This study aimed to evaluate HRQL and investigate the impact of chronic PA infection in MACLD patients. Methods: This cross-sectional study was conducted using the Registry of Prospective Cohort Study including MACLD patients. The 36-item Short-Form health survey (SF-36) and St. George's Respiratory Questionnaire (SGRQ) were administered to assess clinical outcomes. Clinical variables included treatment and sputum culture status, pulmonary function tests, cavitary lesions, and modified Reiff scores on high-resolution computed tomography. Results: The study included 244 MACLD patients (median age, 68 years; 196 women), 19 of whom had chronic PA infection. Modified Reiff score was higher in patients with chronic infection than in those without (P=0.028). Regarding SF-36 scores, physical functioning subscale scores were significantly lower in patients with chronic infection (P=0.029). Additionally, SGRQ symptoms, impact, and total scores were significantly higher in patients with chronic infection. During analysis of covariance comparisons, SGRQ symptoms and impact scores were significantly higher for patients with chronic infection (P=0.043 and 0.021, respectively). Conclusions: MACLD patients with chronic PA infection exhibited significantly higher SGRQ scores, indicating impaired HRQL. Chronic PA infection was significantly associated with the severity of bronchiectasis.
AB - Background: In bronchiectasis patients, chronic Pseudomonas aeruginosa (PA) infection has been associated with worse health-related quality of life (HRQL), but little is known about Mycobacterium avium complex lung disease (MACLD) patients in this context. This study aimed to evaluate HRQL and investigate the impact of chronic PA infection in MACLD patients. Methods: This cross-sectional study was conducted using the Registry of Prospective Cohort Study including MACLD patients. The 36-item Short-Form health survey (SF-36) and St. George's Respiratory Questionnaire (SGRQ) were administered to assess clinical outcomes. Clinical variables included treatment and sputum culture status, pulmonary function tests, cavitary lesions, and modified Reiff scores on high-resolution computed tomography. Results: The study included 244 MACLD patients (median age, 68 years; 196 women), 19 of whom had chronic PA infection. Modified Reiff score was higher in patients with chronic infection than in those without (P=0.028). Regarding SF-36 scores, physical functioning subscale scores were significantly lower in patients with chronic infection (P=0.029). Additionally, SGRQ symptoms, impact, and total scores were significantly higher in patients with chronic infection. During analysis of covariance comparisons, SGRQ symptoms and impact scores were significantly higher for patients with chronic infection (P=0.043 and 0.021, respectively). Conclusions: MACLD patients with chronic PA infection exhibited significantly higher SGRQ scores, indicating impaired HRQL. Chronic PA infection was significantly associated with the severity of bronchiectasis.
KW - 36-item short-form health survey (SF-36)
KW - Colonisation
KW - Health-related quality of life (HRQL)
KW - Mycobacterium avium complex (MAC)
KW - Noncystic fibrosis bronchiectasis (NCFBE)
KW - Nontuberculous mycobacteria (NTM)
KW - Pseudomonas aeruginosa
KW - St. George's Respiratory Questionnaire (SGRQ)
UR - http://www.scopus.com/inward/record.url?scp=85038126942&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038126942&partnerID=8YFLogxK
U2 - 10.1186/s12890-017-0544-x
DO - 10.1186/s12890-017-0544-x
M3 - Article
C2 - 29237500
AN - SCOPUS:85038126942
SN - 1471-2466
VL - 17
JO - BMC Pulmonary Medicine
JF - BMC Pulmonary Medicine
IS - 1
M1 - 198
ER -